Memphasys Ltd. | Income Statement

Fiscal year is July-June. All values AUD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
918.70
124.50
-
-
-
21
Cost of Goods Sold (COGS) incl. D&A
862.90
79.80
19.70
19.40
20.70
21
Gross Income
55.70
44.70
19.70
19.40
20.70
21
SG&A Expense
2,879.00
768.30
1,697.30
1,818.50
2,088.60
1,146.90
EBIT
2,823.20
-
-
-
2,109.30
1,167.90
Unusual Expense
-
-
18.30
-
-
896.20
Non Operating Income/Expense
519.60
205.60
15.90
13.00
337.90
82
Interest Expense
347.80
521.00
682.30
326.00
129.70
277
Pretax Income
2,620.90
1,036.20
2,360.00
2,174.70
1,898.90
401.20
Consolidated Net Income
2,620.90
1,036.20
2,360.00
2,174.70
1,898.90
401.20
Net Income
2,620.90
1,036.20
2,360.00
2,174.70
1,898.90
401.20
Net Income After Extraordinaries
3,399.80
1,769.70
2,074.40
2,043.90
1,797.90
401.20
Net Income Available to Common
2,441.90
3,842.10
2,645.70
2,305.50
1,999.90
401.20
EPS (Basic)
0.14
0.22
0.12
0.07
0.03
-
Basic Shares Outstanding
13,582.10
17,819.10
22,468.50
33,654.80
58,451.40
185,682.30
EPS (Diluted)
0.14
0.22
0.12
0.07
0.03
-
Diluted Shares Outstanding
13,582.10
17,819.10
22,468.50
33,654.80
58,451.40
185,682.30
EBITDA
2,515.00
681.40
1,697.30
1,818.50
2,088.60
1,146.90
Non-Operating Interest Income
30.60
2.80
5.10
2.20
2.20
2.40

About Memphasys

View Profile
Address
30-32 Richmond Road
Sydney New South Wales (NSW) 2140
Australia
Employees -
Website http://www.memphasys.com.au
Updated 07/08/2019
Memphasys Ltd. is a life sciences company, which is engaged in the development, manufacture and sale of pre-cast electrophoresis gels, separations equipment and consumables, analytical software and other biological products for life science market. It operates through the following segments: Consumable Products, Separations, and Corporate. The Consumable Products segment develops, manufactures and distributes pre-cast electrophoresis gels and other biological products into the marketplace.